We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
226
DELISTED
Bed Bath & Beyond Inc
BBBY
| $5.42M | 0.12% |
178,360
+66,500
| +59% | +$2.4M |
|
|
LPNT
227
DELISTED
LifePoint Health, Inc.
LPNT
| $5.4M | 0.12% |
80,388
-124,311
| -61% | -$7.86M |
|
228
NextEra Energy
NEE
$187B
| $5.33M | 0.11% |
152,000
+28,800
| +23% | +$984K |
|
|
XLNX
229
DELISTED
Xilinx Inc
XLNX
| $5.25M | 0.11% |
+81,670
| New | +$5.15M |
|
230
MetLife
MET
$59.5B
| $5.23M | 0.11% |
106,882
+8,370
| +8% | +$388K |
|
231
FMC
FMC
$1.46B
| $5.13M | 0.11% |
80,952
-4,324
| -5% | -$278K |
|
232
Emergent Biosolutions
EBS
$387M
| $5.12M | 0.11% |
150,873
+160
| +0.1% | +$4.94K |
|
233
Genesco
GCO
$388M
| $5.09M | 0.11% |
+150,264
| New | +$6.71M |
|
234
Super Micro Computer
SMCI
$20.2B
| $5.04M | 0.11% |
2,044,190
+93,000
| +5% | +$227K |
|
|
UNVR
235
DELISTED
Univar Solutions Inc.
UNVR
| $4.98M | 0.11% |
170,538
-740
| -0.4% | -$22.4K |
|
236
Zebra Technologies
ZBRA
$12.2B
| $4.96M | 0.11% |
49,370
-7,455
| -13% | -$738K |
|
|
INFN
237
DELISTED
Infinera Corporation Common Stock
INFN
| $4.95M | 0.11% |
463,638
+46,670
| +11% | +$477K |
|
238
Equity Residential
EQR
$25.6B
| $4.92M | 0.11% |
74,730
+17,090
| +30% | +$1.12M |
|
239
White Mountains Insurance
WTM
$5.39B
| $4.81M | 0.1% |
5,539
+1,898
| +52% | +$1.65M |
|
240
News Corp Class A
NWSA
$14.3B
| $4.79M | 0.1% |
350,000
-3,600
| -1% | -$47.1K |
|
241
Danaher
DHR
$135B
| $4.74M | 0.1% |
+63,303
| New | +$4.74M |
|
|
IMPV
242
DELISTED
Imperva, Inc.
IMPV
| $4.7M | 0.1% |
98,210
+16,310
| +20% | +$761K |
|
|
TPC
243
Tutor Perini Cor
TPC
$4.61B
| $4.65M | 0.1% |
161,771
+3,360
| +2% | +$95.5K |
|
244
Graco
GGG
$12.6B
| $4.64M | 0.1% |
127,410
+40,200
| +46% | +$1.43M |
|
245
Hyster-Yale Materials Handling
HY
$594M
| $4.59M | 0.1% |
65,348
+10,000
| +18% | +$681K |
|
246
SiriusPoint
SPNT
$2.91B
| $4.57M | 0.1% |
328,400
+102,137
| +45% | +$1.3M |
|
247
National Bank Holdings
NBHC
$1.93B
| $4.53M | 0.1% |
136,788
+3,600
| +3% | +$115K |
|
248
Douglas Emmett
DEI
$2.03B
| $4.48M | 0.1% |
117,357
+63,580
| +118% | +$2.45M |
|
249
Brinker International
EAT
$7.93B
| $4.47M | 0.1% |
117,420
-16,860
| -13% | -$701K |
|
|
TBI
250
Trueblue
TBI
$232M
| $4.46M | 0.1% |
168,095
+41,725
| +33% | +$1.11M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.